Coombs RRA, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;i:264-6.10.1016/S0140-6736(46)91925-3Search in Google Scholar
Levine P, Backer M, Wigod M, Ponder R. A new human hereditary blood property (cellano) present in 99.8% of all bloods. Science 1949; 109:464-6.10.1126/science.109.2836.46417814514Search in Google Scholar
Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science Ltd., 2002.10.1002/9780470987018Search in Google Scholar
Lewis M, Anstee DJ, Bird GWG, et al. Blood group terminology 1990. ISBT working party on terminology for red cell surface antigens. Vox Sang 1990; 58:152-69.10.1159/000461106Search in Google Scholar
Hughes-Jones NC, Gardner B. The Kell system: Studies with radiolabeled anti-K. Vox Sang 1971; 21:154-8.10.1111/j.1423-0410.1971.tb00572.x5120108Search in Google Scholar
Masouredis SP, Sudora E, Mohan LC, Victoria EJ. Immunoelectron microscopy of Kell and Cellano antigens on red cell ghosts. Haematologia 1980; 13:59-64.Search in Google Scholar
Race RR, Sanger R. Blood groups in man. 6th ed. Oxford, England: Blackwell Scientific Publications, 1975.Search in Google Scholar
Reid ME, Lomas-Francis C. Blood group antigen factsbook. 2nd ed. San Diego:Academic Press, 2003.10.1016/B978-012586585-2/50007-XSearch in Google Scholar
Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997;73:1-11.10.1159/000461892Search in Google Scholar
Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL2l alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490-4.10.1046/j.1537-2995.1996.36696269505.x8669078Search in Google Scholar
Lee S,Wu X, Reid ME, et al. Molecular basis of the Kell (KI) phenotype. Blood 1995;85:912-6.10.1182/blood.V85.4.912.bloodjournal854912Search in Google Scholar
Lee S,Wu X, Reid ME, Redman C. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995;35:822-5.10.1046/j.1537-2995.1995.351096026362.x7570911Search in Google Scholar
Branch DR, Muensch HA, Sy Siok Hian AL, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983;54:573-8.10.1111/j.1365-2141.1983.tb02136.xSearch in Google Scholar
Yazdanbakhsh K, Lee S,Yu Q, Reid ME. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.10.1182/blood.V94.1.310.413k12_310_318Search in Google Scholar
Allen FH, Jr, Lewis SJ, Fudenberg H. Studies of anti- Kpb, a new antibody in the Kell blood group system. Vox Sang 1958;3:1-13.10.1111/j.1423-0410.1958.tb03553.xSearch in Google Scholar
Allen FH, Lewis SJ. Kpa (Penney), a new antigen in the Kell blood group system. Vox Sang 1957;2:81-7.Search in Google Scholar
Øyen R, Halverson GR, Reid ME. Review: conditions causing weak expression of Kell system antigens. Immunohematology 1997;13:75-9.10.21307/immunohematology-2019-711Search in Google Scholar
Anstee DJ. Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1-20.10.1111/j.1423-0410.1990.tb02049.xSearch in Google Scholar
Øyen R, Powell VI, Reid ME, et al. The first non- CGD McLeod phenotype male to make anti-Kx: definition of the molecular basis (abstract). Transfusion l999;39(suppl l):9OS.Search in Google Scholar
Southcott MJG, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93:4425-35.10.1182/blood.V93.12.4425Search in Google Scholar
Vaughan JI, Warwick R, Letsky E, et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.10.1016/0002-9378(94)90477-4Search in Google Scholar
Daniels G, Hadley A, Green GA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003;43:115-6.10.1046/j.1537-2995.2003.00327.x12519439Search in Google Scholar
Grant SR, Kilby MD, Meer L, et al. The outcome of pregnancy in Kell a⊓oimmunisation. BJOG 2000; 107:481-5.10.1111/j.1471-0528.2000.tb13266.x10759266Search in Google Scholar
Wagner T, Resch B, Reiterer Ę Gassner C. Pancytopenia due to suppressed hematopoiesis in a case of fatal HDN due to anti-Kl and necessity of molecular KI typing (abstract). Transfusion 2002; 42(suppl):43S-44S.Search in Google Scholar
Dhodapkar KM, Blei F. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001;23:69-70.10.1097/00043426-200101000-0001811196277Search in Google Scholar
Wagner T, Lanzer G, Geissler K. Kell expression on myeloid progenitor cells. Leuk Lymphoma 2002; 43:479-85.10.1080/1042819029001194912002749Search in Google Scholar
Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 1991;88:6353-7.10.1073/pnas.88.14.6353520811712490Search in Google Scholar
Advani H, Zamor J, Judd WJ, et al. Inactivation of Kell blood group antigens by 2-aminoethylisothio- uronium bromide. Br J Haematol 1982;51:107-15.10.1111/j.1365-2141.1982.tb07295.x7073987Search in Google Scholar
Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion l99O;30:158-67.10.1046/j.1537-2995.1990.30290162904.x2407001Search in Google Scholar
Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003;102:3028-34.10.1182/blood-2003-05-156412842980Search in Google Scholar
Cartron JP, Bailly P, Le Van Kim C, et al. Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang l998;74(suppl 2):29-64.10.1111/j.1423-0410.1998.tb05397.x9704424Search in Google Scholar
Lee S, Zambas ED, Marsh WL, Redman CM. The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 1993;81:2804-9.10.1182/blood.V81.10.2804.2804Search in Google Scholar
Lee S, Zambas E, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-70.10.1182/blood.V85.5.1364.bloodjournal8551364Search in Google Scholar
Lee S, Russo DCW, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;276:27281-9.10.1074/jbc.M10343320011375401Search in Google Scholar
Yu LC,Twu YC, Chang CY, Lin M. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001; 276:10247-52.10.1074/jbc.M00987920011134029Search in Google Scholar
Lee S, Russo DCW, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the Kellmod red cell phenotype. Transfusion 2003;43:1121-5.10.1046/j.1537-2995.2003.00472.xSearch in Google Scholar
Bertelson CJ, Pogo AO, Chaudhuri A, et al. Localization of the McLeod locus (XK) within Xp2l by deletion analysis. Am J Hum Genet 1988; 42:703-11.Search in Google Scholar
Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001;50:755-64.10.1002/ana.10035Search in Google Scholar
Russo DC, Øyen R, Powell VI, et al. First example of anti-Kx in a person with McLeod phenotype and without chronic granulomatous disease. Transfusion 2OOO;40:1371-5.10.1046/j.1537-2995.2000.40111371.xSearch in Google Scholar
Russo DCW Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Transfusion 2002;42:287-93.10.1046/j.1537-2995.2002.00049.xSearch in Google Scholar
Ho MF, Chalmers RM, Davis MB, et al. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996;39:672-5.10.1002/ana.410390518Search in Google Scholar
Hanaoka N, Yoshida K, Nakamura A, et al. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family. J Neurol Sci 1999;165:6-9.10.1016/S0022-510X(99)00028-3Search in Google Scholar
Kawakami T,TakiyamaY,YoshiokaT, et al. A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci 1999;166:36-9.10.1016/S0022-510X(99)00108-2Search in Google Scholar
